Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsBeyond The WallsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutSpecial ReportViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

GLAUCOMA 360

Community-based screening programs promising for glaucoma

ByLaird Harrison
February 3rd 2019

Glaucoma genetics working toward a cure

ByLaird Harrison
February 2nd 2019
Advertisement

Cell therapy shows promise in glaucoma

ByLaird Harrison
February 2nd 2019

Virtual reality proposed for glaucoma perimetry

ByLaird Harrison
February 2nd 2019

Innovation is the focus of New Horizon Forum

ByBeth Thomas Hertz
January 31st 2019

Education is focus of final day of Glaucoma 360

ByBeth Thomas Hertz
January 31st 2019
Advertisement
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Prev
Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy

2

Alcon raises offer in amended deal to acquire STAAR Surgical

3

Neurotrophic keratitis outcomes improve with early, stage-based care

4

FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD

5

Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us